Cross Martin L, Lambeth Matthew R, Aldwell Frank E
Centre for Innovation, University of Otago, Dunedin, New Zealand.
Immunol Cell Biol. 2008 Feb;86(2):214-7. doi: 10.1038/sj.icb.7100126. Epub 2007 Nov 13.
Oral vaccination of mice with live Mycobacterium bovis BCG in lipid-formulation induces a gamma-interferon response that can be measured systemically, and confers protection against aerosolized mycobacterial challenge. Here, we have investigated cytokine responses following the vaccination, drawing comparisons between mice that received single or multiple oral immunizations and between mice receiving formulations containing live BCG or non-replicating mycobacterial antigens. Single oral immunization with lipid-formulated live BCG invoked secreted and cellular IFN-gamma responses in mice 8 weeks post-vaccination, the magnitudes of which were significantly elevated in mice receiving multiple immunizations over the 8-week period. Single oral immunization with live BCG also invoked an interleukin-2 response (but not TNF-alpha or IL-4), although the magnitude was not elevated by multiple immunizations. Multiple immunizations with lipid-formulated soluble or particulate non-replicating mycobacterial antigens failed to invoke cytokine responses, except for a low-level IFN-gamma response in mice multiple immunized with lipid-formulated heat-killed BCG. These results are discussed in contrast to the known patterns of cytokine induction following parenteral-route immunization with live or non-replicating mycobacterial antigens and with practical reference to the development of oral-delivery vaccines against tuberculosis.
用脂质制剂形式的活牛分枝杆菌卡介苗对小鼠进行口服疫苗接种可诱导全身可测量的γ-干扰素反应,并赋予其抵抗雾化分枝杆菌攻击的保护作用。在此,我们研究了疫苗接种后的细胞因子反应,比较了接受单次或多次口服免疫的小鼠以及接受含活卡介苗或非复制性分枝杆菌抗原制剂的小鼠之间的情况。用脂质制剂形式的活卡介苗进行单次口服免疫在接种疫苗8周后的小鼠中引发了分泌型和细胞型干扰素-γ反应,在8周期间接受多次免疫的小鼠中,其反应强度显著升高。用活卡介苗进行单次口服免疫也引发了白细胞介素-2反应(但不是肿瘤坏死因子-α或白细胞介素-4),尽管多次免疫并未使其反应强度升高。用脂质制剂形式的可溶性或颗粒性非复制性分枝杆菌抗原进行多次免疫未能引发细胞因子反应,除了在用脂质制剂形式的热灭活卡介苗多次免疫的小鼠中出现低水平的干扰素-γ反应。将这些结果与用活的或非复制性分枝杆菌抗原进行肠胃外途径免疫后已知的细胞因子诱导模式进行了对比讨论,并实际参考了抗结核口服递送疫苗的开发情况。